ProQR Therapeutics N.V. Gains Losses Recognised When Control In Subsidiary Is Lost
ProQR Therapeutics N.V. (PRQR) reported Gains Losses Recognised When Control In Subsidiary Is Lost of EUR 92.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Income Statement › Other Income
ifrs-full:GainsLossesRecognisedWhenControlInSubsidiaryIsLost · last filed 2026-03-12
- ProQR Therapeutics N.V. gains losses recognised when control in subsidiary is lost for the quarter ending 2023-12-31 was 0.00 EUR.
- ProQR Therapeutics N.V. gains losses recognised when control in subsidiary is lost for the quarter ending 2023-09-30 was 92.00K EUR.
| Period end | Gains Losses Recognised When Control In Subsidiary Is Lost 3 month | Gains Losses Recognised When Control In Subsidiary Is Lost 6 month | Gains Losses Recognised When Control In Subsidiary Is Lost 9 month | Gains Losses Recognised When Control In Subsidiary Is Lost 12 month |
|---|---|---|---|---|
| 2023-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 92.00K EUR derived: sum of 2 quarters · filed 2026-03-12 | 92.00K EUR 20-F · filed 2026-03-12 | |
| 2023-09-30 | 92.00K EUR 6-K · filed 2024-11-07 | 92.00K EUR 6-K · filed 2024-11-07 |